Trials / Terminated
TerminatedNCT00387829
DuraGen Plus® Adhesion Barrier for Use in Spinal Surgery
Randomized Controlled Trial of DuraGen Plus® Adhesion Barrier Matrix to Minimize Adhesions Following Lumbar Discectomy
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 347 (actual)
- Sponsor
- Integra LifeSciences Corporation · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the safety and effectiveness of DuraGen Plus® Adhesion Barrier Matrix as an adhesion barrier in spinal surgery to reduce the extent of peridural fibrosis formation and radicular pain in comparison to a control group receiving standard care.
Detailed description
For more information, please visit www.DuragenStudy.com
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | DuraGen Plus Adhesion Barrier Matrix | Application of DuraGen Plus Adhesion Barrier Matrix in spine surgery |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2010-12-01
- Completion
- 2011-12-01
- First posted
- 2006-10-13
- Last updated
- 2017-09-07
- Results posted
- 2013-11-20
Locations
36 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00387829. Inclusion in this directory is not an endorsement.